BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4678135)

  • 1. [A new bronchospasmolytic].
    Brunner R
    Arzneimittelforschung; 1972 Jul; 22(7):1223-5. PubMed ID: 4678135
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hexoprenaline on blood pressure].
    Lageder H; Hitzenberger G; Thoma F; Irsigler K
    Int J Clin Pharmacol; 1974 Sep; 10(2):90-4. PubMed ID: 4448556
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexoprenaline--a new bronchodilator.
    Vermaak JC; De Kock MA; Joubert JR
    S Afr Med J; 1972 Dec; 46(51):1999-2001. PubMed ID: 4651880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the bronchospasmolytic activity of alupent and ipradol].
    Makel'skiĭ VV; Iartsev SS
    Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508
    [No Abstract]   [Full Text] [Related]  

  • 5. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 6. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
    Giles RE; Williams JC; Finkel MP
    J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K
    Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cumulative dosage study on the effect of NAB 365 and fenoterol on the values of pulmonary function, blood pressure, pulse rate and general tolerance].
    Uhl O
    Arzneimittelforschung; 1974 Jun; 24(6):855-8. PubMed ID: 4152655
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise-induced bronchospasm: evaluation of metaproterenol.
    Sly RM; Heimlich EM; Ginsburg J; Busser RJ; Strick L
    Ann Allergy; 1968 May; 26(5):253-8. PubMed ID: 5654963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of the broncho-relaxing action of a new sympathicomimetic drug on twenty patients with chronic obstructive lung disease (author's transl)].
    Sergysels R; Leblanc G; Payfa M; Hennebert A
    Acta Tuberc Pneumol Belg; 1973; 64(1):80-8. PubMed ID: 4768064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative bronchodilator effects of inhaled terbutaline aerosols and other beta-adrenergics].
    Roberts M; Petit JM
    Acta Tuberc Pneumol Belg; 1971; 62(2):180-91. PubMed ID: 4398796
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of intravenous hexoprenaline in asthma.
    Benjamin C; van As A
    S Afr Med J; 1972 May; 46(20):599-603. PubMed ID: 4402654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bronchodilator effect of fenoterol. Duration of activity and use in the basic treatment of bronchospasm].
    Dierckx JP; Gillard C; Gossart R
    Brux Med; 1974 May; 54(5):297-301. PubMed ID: 4429838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double blind trial of hexoprenaline as a bronchodilator].
    Ulmer WT
    Arzneimittelforschung; 1974 May; 24(5):840-1. PubMed ID: 4603484
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of bricanyl (Terbutaline) on ventilatory capacity in patients with asthma.
    Maranetra N; Pain MC
    Med J Aust; 1973 May; 1(20):988-90. PubMed ID: 4716586
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrbuterol: a new bronchodilator. Phase I-single dose study.
    Steen SN; Ziment I; Thomas JS
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance.
    Bäcklund L; Fagerberg E
    Scand J Respir Dis; 1968; 49(4):284-90. PubMed ID: 5194717
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
    Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
    Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.